ADMA Biologics (ADMA) director exercises options and gifts 60,000 shares
Rhea-AI Filing Summary
ADMA Biologics director Lawrence P. Guiheen reported a mix of option exercises and charitable estate planning transactions. On March 13, 2026, he exercised stock options to acquire 30,000 shares of common stock at $3.66 per share, increasing his direct equity stake. On March 17, 2026, he made bona fide gifts totaling 60,000 shares of common stock, including 30,000 shares transferred directly and 30,000 shares gifted to the 2019 Guiheen Irrevocable Trust, over which he retains control but disclaims beneficial ownership except for any pecuniary interest. After these transactions, he holds 105,520 shares directly, with additional shares held indirectly through irrevocable trusts as described in the footnotes.
Positive
- None.
Negative
- None.
Insights
Routine option exercise paired with non-market gifts, net effect neutral.
The reporting person exercised stock options to acquire 30,000 shares of ADMA Biologics common stock at an exercise price of $3.66. No same-day sales are reported, so this looks like an exercise-and-hold pattern that increases direct ownership.
He also made bona fide gifts totaling 60,000 shares, with 30,000 shares transferred to the 2019 Guiheen Irrevocable Trust and 30,000 shares given directly, both coded as gifts (G). Gifts are non-market transfers with no sale proceeds and usually carry limited signaling value about the insider’s view of the stock.
Following these moves, he reports 105,520 shares held directly and additional indirect holdings through irrevocable trusts as described in the footnotes. The filing shows no open‑market buying or selling, and the transactionSummary indicates neutral net buy/sell shares, suggesting this is largely routine compensation and estate planning activity rather than a major change in stance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock | 30,000 | $0.00 | -- |
| Gift | Common Stock | 30,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 30,000 | $0.00 | -- |
| Exercise | Common Stock | 30,000 | $3.66 | $110K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Includes, as of the transaction date, (i) 10,690 RSUs granted on February 9, 2026, which will fully vest on February 9, 2027, subject to the Reporting Person's continued service as of such vesting date; and (ii) 94,830 shares of common stock owned by the Reporting Person. This transaction involved the Reporting Person's gift of 30,000 shares of Issuer common stock to the Lawrence P Guiheen Irrevocable Trust DTD 9/20/19, Arlene Guiheen TTEE, Katherine M Guiheen TTEE (the "2019 Guiheen Irrevocable Trust"), over which Mr. Guiheen retains control. The Reporting Person disclaims beneficial ownership of the securities held by the 2019 Guiheen Irrevocable Trust, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Includes 30,000 shares of common stock held in the 2019 Guiheen Irrevocable Trust. Includes 50,990 shares of common stock held in the Lawrence P Guiheen Irrevocable Trust 1. The Reporting Person is exercising this option due, in part, to its near-term expiration date. These options vested in twenty-four equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.
